Interstate Drug Shipment Rules Planned by FDA Amid Court Fight

The FDA will write regulations around interstate shipments of drugs between pharmacies after suspending a standard agreement that’s been caught up in litigation since its release.

The Food and Drug Administration intends to use the notice-and-comment rulemaking process to “codify provisions” of a memorandum of understanding with states involving shipments of compounded medications, according to a Tuesday filing with the U.S. District Court for the District of Columbia. Compounded drugs are those mixed by a pharmacist for a specific patient based on a doctor’s prescription.

The rulemaking will open the door for pharmacies and other stakeholders to weigh in on ...